ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Identifying Affected Tissues and Disease Severity in PsA

Identifying Affected Tissues and Disease Severity in PsA

  • Dactylitis (©Beachbird/Shutterstock.com)
    Dactylitis (©Beachbird/Shutterstock.com)
Psoriatic arthritis (PsA) requires a comprehensive care approach that includes the recognition of treatment risks. In this slideshow, we highlight recommended treatments and related risks associated with PsA.
 
“The overall management of patients with PsA is complex and requires the adoption of a more patient-focused multidisciplinary approach,“ write Martin Bergman and Amy Lundholm in the March issue of Arthritis Research & Therapy.
 
The authors point out that, “The clinical spectrum of PsA is extremely diverse in both disease severity and tissues affected, and this disorder often occurs in conjunction with several associated comorbidities.”
 
For more information about the report, please see:  "Reducing Treatment Risks in PsA."
 
References: 

Martin Bergman and Amy Lundholm. “Mitigation of disease- and treatment- related risks in patients with psoriatic arthritis,” Arthritis Research & Therapy. Published online Mar, 20, 2017. DOI: 10.1186/s13075-017-1265-5

 

Add new comment

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.